Purpose: When faced with treatment choices for early stage prostate cancer,
patients must balance the survival benefit of a treatment with its morbidi
ty. Little is known about how patients balance these trade-offs. To further
our understanding of patient decision making we assessed patient utilities
for prostate cancer treatment related morbidities. We determined whether p
atient utilities were predicted by sociodemographic characteristics or base
line genitourinary function.
Materials and Methods: We evaluated 401 men undergoing prostate needle biop
sy for suspicion of prostate cancer at university, Veterans Affairs and pub
lic hospitals. Study design included a prospective cross-sectional cohort w
ith correlation and multivariate analysis. Subjects were studied with 2 est
ablished health related quality of life instruments. Patient utilities were
assessed with an interactive software application.
Results: On multivariate analysis utility for current general health was a
significant predictor of utilities for treatment related morbidities. Surpr
isingly baseline urinary, sexual and bowel function scores did not correlat
e well with respective utilities for potential incontinence, impotence or r
adiation proctitis. In other words, men with good and imperfect baseline fu
nction were equally willing to risk impairment to preserve life.
Conclusions: Men who perceived that general health was better appear to pla
ce higher value on quantity of life, while those who already are suffering
from poor general health place higher value on quality of life. Ethnicity a
ppears to modify some effects of other variables on patient preference. Uti
lity assessment provides a quantitative tool to aid physicians in counselin
g patients when making treatment decisions for localized prostate cancer.